ACE and heart failure: Additional heart failure therapies included angiotensin receptor-neprilysin inhibitors (54.8%), ACE inhibitors (22.0%), angiotensin receptor blockers (12.9%), potassium-sparing diuretics (64.5%), and loop diuretics (67.7%).